NEW YORK, Sept. 15, 2024 /PRNewswire/ — Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Rentokil Initial plc (“Rentokil” or “the Company”) (NYSE: RTO). Investors who purchased Rentokil securities are encouraged to obtain additional…

NEW YORK, Sept. 15, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Taro Pharmaceutical Industries Ltd. (“Taro” or “the Company”) (NYSE: TARO) and…

NEW YORK, Sept. 15, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Aviat Networks, Inc. (“Aviat” or “the Company”) (NASDAQ: AVNW). Investors who purchased Aviat securities are encouraged to…

NEW YORK, Sept. 15, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Transocean Ltd. (“Transocean” or “the Company”) (NYSE: RIG). Investors who purchased Transocean securities are encouraged to…

NEW YORK, Sept. 15, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dyne Therapeutics, Inc. (“Dyne” or “the Company”) (NASDAQ: DYN). Investors who purchased Dyne securities are encouraged to…

NEW YORK, Sept. 15, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. (“Acadia Healthcare” or “the Company”) (NASDAQ: ACHC). Investors who purchased Acadia Healthcare…

NEW YORK, Sept. 15, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Flux Power Holdings, Inc. (“Flux” or “the Company”) (NASDAQ: FLUX). Investors who purchased Flux securities are encouraged to…

NEW YORK-, Sept. 15, 2024 /PRNewswire/ — Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fulcrum Therapeutics, Inc. (“Fulcrum” or “the Company”) (NASDAQ: FULC). Investors who purchased Fulcrum securities are encouraged to obtain additional…

NEW YORK, Sept. 15, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Spire Global, Inc. (“Spire” or “the Company”) (NYSE: SPIR) and certain of its…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.